New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - eplerenone 50mg; eplerenone 50mg - film coated tablet - 50 mg - active: eplerenone 50mg excipient: croscarmellose sodium hypromellose lactose monohydrate magnesium stearate microcrystalline cellulose opadry yellow purified talc purified water   sodium laurilsulfate active: eplerenone 50mg excipient: croscarmellose sodium hypromellose lactose monohydrate magnesium stearate microcrystalline cellulose opadry yellow purified talc purified water   sodium laurilsulfate - inspra is indicated to reduce the risk of cardiovascular death in combination with standard therapy in patients who have evidence of heart failure and left ventricular impairment within 3 to 14 days of an acute myocardial infarction.

Israel - English - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - eplerenone - film coated tablets - eplerenone 25 mg - eplerenone - inspra is indicated, in addition to standard therapy including beta-blockers, to reduce the risk of cardiovascular mortality and morbidity in stable patients with left ventricular dysfunction (lvef < or = 40 % ) and clinical evidence of heart failure after recent myocardial infarction.inspra is indicated in addition to standard optimal therapy, to reduce the risk of cardiovascular morbidity and mortality in adult patients with nyha class ii (chronic) heart failure and left ventricular systolic dysfunction (lvef < or = 30%).

Israel - English - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - eplerenone - film coated tablets - eplerenone 50 mg - eplerenone - inspra is indicated, in addition to standard therapy including beta-blockers, to reduce the risk of cardiovascular mortality and morbidity in stable patients with left ventricular dysfunction (lvef < or = 40 % ) and clinical evidence of heart failure after recent myocardial infarction.inspra is indicated in addition to standard optimal therapy, to reduce the risk of cardiovascular morbidity and mortality in adult patients with nyha class ii (chronic) heart failure and left ventricular systolic dysfunction (lvef < or = 30%).

Spain - Spanish - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

viatris healthcare limited - eplerenona - comprimido recubierto con pelÍcula - 25 mg - eplerenona 25 mg - eplerenona

Spain - Spanish - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

viatris healthcare limited - eplerenona - comprimido recubierto con pelÍcula - 50 mg - eplerenona 50 mg - eplerenona

Serbia - Serbian - Агенција за лекове и медицинска средства Србије (Agencija za lekove i medicins)

viatris healthcare d.o.o. - eplerenon -

Serbia - Serbian - Агенција за лекове и медицинска средства Србије (Agencija za lekove i medicins)

viatris healthcare d.o.o. - eplerenon -

Romania - Romanian - ANMDM (Agenția Națională a Medicamentului și a Dispozitivelor Medicale din România)

fareva amboise - franta - eplerenonum - compr. film. - 25mg - diuretice care economisesc potasiul antagonisti ai aldosteronului (antialdosteronice)

Romania - Romanian - ANMDM (Agenția Națională a Medicamentului și a Dispozitivelor Medicale din România)

fareva amboise - franta - eplerenonum - compr. film. - 50mg - diuretice care economisesc potasiul antagonisti ai aldosteronului (antialdosteronice)

Romania - Romanian - ANMDM (Agenția Națională a Medicamentului și a Dispozitivelor Medicale din România)

fareva amboise - franta - eplerenonum - compr. film. - 25mg - diuretice care economisesc potasiul antagonisti ai aldosteronului (antialdosteronice)